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Introduction: Campylobacter is an important causative agent of intestinal infections in humans. Bacteremia is
detected in less than 1% of patients, mainly in immunocompromised patients and in extreme age groups. Cellulitis
is a relatively common manifestation of Campylobacter infection, but concomitant bacteremia is a rare event.
Infections of the pacemaker area are caused primarily by staphylococci, followed by fungi, streptococci and
Gram-negative rods. To the best of our knowledge, this is the first case report of pacemaker pocket infection and
bacteremia caused by Campylobacter fetus.
Case presentation: A 72-year-old Croatian Caucasian man with myelodysplasia, impaired fasting glucose levels and
a recently implanted permanent pacemaker was admitted to hospital after six days of fever, development of red
swelling of the pacemaker pocket area and worsening of his general condition. No antibiotic therapy was
introduced in the outpatient setting. He denied any recent gastrointestinal disturbances. With the exception of an
elevated leukocyte count, erythrocyte sedimentation rate, and C-reactive protein and blood glucose levels, other
laboratory findings were normal. Treatment with vancomycin plus netilmicin was introduced, and a surgical incision
with drainage of the pacemaker pocket was performed. The entire pacemaker system was removed and a new one
re-implanted after 14 days of antibiotic therapy. Transesophageal echocardiography showed no pathological
findings. Three subsequent blood cultures obtained on admission as well as swab culture of the incised pacemaker
area revealed Campylobacter fetus; stool and pacemaker lead cultures were negative. According to the
microbiological results, antibiotic therapy was changed to ciprofloxacin plus netilmicin. A clinical examination and
the results of a laboratory analysis performed after two weeks of therapy were within normal limits.
Conclusion: Myelodysplasia, impaired fasting glucose levels and older age could be contributing factors for the
development of bacteremic Campylobacter fetus cellulitis. Emergent surgical and antibiotic treatment are mandatory
and provide the optimal outcome for such types of pacemaker pocket infection.Introduction
To date, 15 species of Campylobacter are known.
Campylobacter is an important cause of intestinal infec-
tion in humans. These microorganisms sporadically cause
bacteremia or extraintestinal infections [1]. Less than
1% of patients with diarrhea caused by Campylobacter
species develop bacteremia. Invasive disease usually oc-
curs in immunocompromised patients and in persons at
the extremes of age [2]. Contaminated poultry, meat and* Correspondence: dledina@kbsplit.hr
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reproduction in any medium, provided the orunpasteurized milk are usual sources of Campylobacter
infection, but direct spreading from infected animals is
also possible. Intestinal infections are most commonly
caused by C. jejuni [3]. Extraintestinal manifestations are
rare and include meningitis, endocarditis, septic arthritis
and osteomyelitis [4,5]. C. fetus has been recognized as
the major causative agent of extraintestinal infections.
Cellulitis is a relatively common manifestation of Cam-
pylobacter infection but concomitant bacteremia is rare
[6]. Infections of the pacemaker area are primarily caused
by staphylococci, followed by fungi, streptococci andLtd. This is an Open Access article distributed under the terms of the Creative
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maker system is associated with high mortality [7].
Cases of C. fetus endocarditis [1], as well as infection
of an internal cardioverter defibrillator [8], have pre-
viously been described. To the best of our knowledge,
only one article regarding pacemaker site Campylobacter
infection has been published thus far [9]. We report the
case of a patient with myelodysplasia and diabetes mel-
litus who, 14 days after implantation of a permanent
pacemaker, developed bacteremic cellulitis of a pacemaker
site infection caused by C. fetus.
Case presentation
A 72-year-old Croatian Caucasian man was admitted to
our hospital with fever of up to 40°C, inflammation of
the pacemaker pocket area and progressive general
weakness. Five years prior to this hospital admission, our
patient was diagnosed with myelodysplastic syndrome
and he had an impaired fasting glucose level that was
treated with diet only. The current symptoms com-
menced two weeks after the implantation of a perma-
nent pacemaker. He developed low grade fever up to
37.5°C accompanied by general weakness. On the se-
venth day of his disease, fever with chills rose up to 40°C
and he was referred to our Department of Infectious
Diseases. He denied any gastrointestinal disturbances in-
cluding diarrhea or abdominal pain during or before this
illness. He also denied close contact with animals and
eating of undercooked meat or unpasteurized milk. He
received no antibiotic therapy in the outpatient setting.
On physical examination there was painful red swel-
ling of the pacemaker area, 15cm in diameter, with
dehiscence of the surgical suture and serous leakage evi-
dent on his right chest region. His heart rhythm was
regular with a systolic heart murmur, but our patient
was hemodynamically stable. His arterial pressure was
140/70mmHg, and heart rate 84 beats/min. Bronchial
rales were heard on the right side of his chest. He-
patomegaly and splenomegaly were not registered. La-
boratory tests revealed an erythrocyte sedimentation
rate of 96mm/h. His leukocyte count was 17.9×109/L
(86% polymorphonuclear cells), erythrocytes 2.86×1012/L,
hemoglobin concentration 9.9g/dL and platelet count
242×109/L. His C-reactive protein level was 156μmol/L,
and blood glucose level 9.06mmol/L. Other blood bio-
chemical parameters (creatinine, blood urea nitrogen, total
protein, albumin, globulin, immunoglobulin, amylase, se-
rum aspartate aminotransferase, alanine aminotransferase,
bilirubin, creatine phosphokinase and alkaline phosphates)
were within the reference ranges. A chest X-ray showed
no pulmonary infiltrations. Transthoracic, as well as tran-
sesophageal echocardiography showed no signs of en-
docarditis. Blood, urine and wound swabs were obtained
and vancomycin plus netilmicin introduced as empirictherapy. Swab culture of the infected region and three
consecutive blood cultures revealed C. fetus. Urine, stool
and pacemaker lead cultures obtained later, were negative.
Cultures of swabs and blood samples, plated on charcoal-
based blood-free selective medium, incubated under micro-
aerobic (5% O2, 10% CO2 and 85% N2) conditions at 25°C
and 35°C resulted in the growth of gray, flat, irregular,
spreading colonies after 48 hours.
The Gram stain showed a characteristic appearance of
Gram-negative, curved to S-shaped rods. The identifica-
tion of the strain was performed on the basis of conven-
tional biochemical tests. An antibiotic susceptibility test,
performed by using the E-test (PDM Epsilometer; AB
Biodisc, Solna, Sweden), gave these minimum inhibitory
concentrations for the following antimicrobial agents:
ampicillin 0.12mg/L, tetracycline 0.25mg/L, erythromycin
0.19mg/L and ciprofloxacin 0.064mg/L. Minimum inhibi-
tory concentration breakpoints were interpreted according
to the guideline established by the British Society for Anti-
microbial Chemotherapy.
Our patient was transferred to our Department of Car-
diology where a local surgical incision and removal of the
permanent pacemaker by simple traction were performed.
The pacemaker pocket was drained and the wound closed
by secondary sutures. Surgical drainage was followed by
an immediate drop in the fever. According to the anti-
biotic susceptibility of C. fetus, therapy was switched to
ciprofloxacin plus netilmicin. Our patient’s condition
improved quickly following the treatment. Repeated blood
cultures obtained during and at the end of the second
week of therapy were negative. A new pacemaker system
was re-implanted 14 days after his admission to our
hospital, at the contralateral side of his thorax. Three
days later, our patient was discharged from hospital.
One month later, the area of cellulitis had healed com-
pletely, and there were no signs of inflammation of the
contralaterally implanted pacemaker.
Discussion
This is the first case report of pacemaker pocket infection
and bacteremia caused by C. fetus. Bacteremia caused by
C. fetus is a rare event, particularly in immunocompetent
hosts [5]. C. fetus has an affinity for vascular endothelium,
and different cardiovascular complications such as en-
docarditis, thrombophlebitis, pericarditis and mycotic
aneurysms have been reported [1,5]. Some degree of im-
munodeficiency appears to be mandatory for the develop-
ment of extraintestinal Campylobacter infections. C. fetus
bacteremia is a serious infection that is often accom-
panied by relapses and complications despite the prompt
administration of the appropriate antibiotics [5]. Human
immunodeficiency virus infection, alcoholism, cirrhosis,
old age, pregnancy, diabetes mellitus, malignancies, beta-
thalassemia, systemic lupus erythematosus, inherited
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have all been recognized as important risk factors for the
development of serious C. fetus infection [5,6]. In our pa-
tient, diabetes mellitus and myelodysplasia could have
been contributing factors to the severe pacemaker pocket
infection and bacteremia. Another recognized cause of
serious extraintestinal infections is C. lari. After reviewing
the literature, we found one case of pacemaker infection
caused by C. lari [9]. In eight cases of C. lari bacteremia,
only two had gastrointestinal symptoms [9,10]. Isolation
of C. lari and C. fetus in several cases of prosthetic device
infections encouraged an opinion of their propensity to
cause such types of infections [11,12].
Although in our case, an intestinal source of infection
was not proven, it cannot be ruled out as a stool culture
was obtained during empiric therapy that included an
aminoglycoside. The negative culture of the pacemaker
lead could also be a consequence of previously intro-
duced aminoglycoside therapy. Therefore, the mode of
pacemaker pocket infection for our patient remains un-
clear: direct inoculation during insertion of the pacemaker
or hematogenous spread originating from an asympto-
matic intestinal infection.
Most authors recommend a combination of removal
of cardiac devices, either surgically or by a transvenous
route, with antimicrobial therapy [13]. Percutaneous re-
moval of infected pacemakers combined with appropriate
antibiotic therapy is safe and effective, as shown in our
case. Both simple traction and countertraction techniques
can be used with low risk of complications [14]. The mor-
tality of patients with retained infected pacemaker systems
is high. Therefore, removal of both the pacemaker gene-
rator and leads is essential in case of an infection. Fortu-
nately, as in our case, pulse generator pocket infection is
quite rarely complicated by infective endocarditis [15].Conclusion
C. fetus is a rare but possible cause of serious pacemaker
pocket site infection. In particular it should be considered
as a causative agent in patients with underling illnesses
that are contributing factors for a wider spectrum of
causative agents. The best treatment results are obtained
with a combination of surgical and antimicrobial therapy.Consent
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